Israel Englander’s Loxo Oncology, Inc LOXO Stock Holding History

Israel Englander’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-214,514	Closed	-$30M	–	4544
2018 Q4	$30M	Buy	+214,514	New	+$32.6M	0.05%	532
2018 Q3	–	Sell	-21,417	Closed	-$3.71M	–	4509
2018 Q2	$3.71M	Buy	21,417 +6,019	+39%	+$905K	﹤0.01%	1996
2018 Q1	$1.78M	Buy	15,398 +7,312	+90%	+$778K	﹤0.01%	2388
2017 Q4	$681K	Buy	+8,086	New	+$674K	﹤0.01%	2940
2016 Q1	–	Sell	-9,624	Closed	-$274K	–	3855
2015 Q4	$274K	Buy	+9,624	New	+$258K	﹤0.01%	2942
2015 Q3	–	Sell	-47,000	Closed	-$847K	–	3891
2015 Q2	$847K	Sell	47,000 -262,516	-85%	-$3.59M	﹤0.01%	2362
2015 Q1	$3.85M	Buy	309,516 +273,900	+769%	+$3.41M	0.01%	1557
2014 Q4	$418K	Sell	35,616 -64,384	-64%	-$750K	﹤0.01%	3123
2014 Q3	$1.31M	Buy	+100,000	New	+$1.3M	﹤0.01%	2130

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $5.27B AUM 41.17% 1-Year Est. Return

Israel Englander's LOXO Position: Q1 2019 in Review

Israel Englander sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 214,514 shares — an estimated $30M sold.

Israel Englander first reported a position in LOXO in Q3 2014 and held it in 9 quarters. The position peaked at $30M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Israel Englander reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Israel Englander sold 214,514 Loxo Oncology, Inc shares in Q1 2019, an estimated $30M.
Israel Englander first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 9 quarters.
Israel Englander's Loxo Oncology, Inc position peaked at $30M in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.